SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-23-128382 from TriSalus Life Sciences, Inc. (TLSI)

TriSalus Life Sciences, Inc.
Date: Dec. 21, 2023 · CIK: 0001826667 · Accession: 0001104659-23-128382

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-276070

Date
December 21, 2023
Author
Mary Szela
Form
CORRESP
Company
TriSalus Life Sciences, Inc.

Letter

TriSalus Life Sciences, Inc.

6272 W. 91st Ave.

Westminster, Colorado 80031

December 21, 2023

Securities and Exchange Commission

Division of Corporation Finance

Office of Technology

100 F. Street N.E.

Washington, D.C. 20549-3010

Attention: Juan Grana

Re: TriSalus Life Sciences, Inc.

Registration Statement on Form S-1

File No. 333-276070

Ladies and Gentlemen:

TriSalus Life Sciences, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on Tuesday, December 26, 2023, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez of Cooley LLP, counsel to the Registrant, at (858) 550-6157.

[Signature Page Follows]

Very truly yours,
TRISALUS LIFE SCIENCES, INC.

Show Raw Text
CORRESP
1
filename1.htm

TriSalus
Life Sciences, Inc.

6272 W. 91st Ave.

Westminster, Colorado 80031

December 21, 2023

Securities and Exchange Commission

Division of Corporation Finance

Office of Technology

100 F. Street N.E.

Washington, D.C. 20549-3010

Attention: Juan Grana

Re:          TriSalus Life Sciences, Inc.

Registration Statement on Form S-1

File No. 333-276070

Ladies and Gentlemen:

TriSalus Life Sciences, Inc. (the “Registrant”)
hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause
the above-referenced Registration Statement on Form S-1 to become effective on Tuesday, December 26, 2023, at 4:00 p.m., Eastern Time,
or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of
the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP, counsel to the Registrant, to make such request on its
behalf.

Once the Registration Statement has been declared
effective, please orally confirm that event with Carlos Ramirez of Cooley LLP, counsel to the Registrant, at (858) 550-6157.

[Signature Page Follows]

    Very truly yours,

    TRISALUS LIFE SCIENCES, INC.

    By:
     /s/ Mary Szela

    Name: Mary Szela

    Title: Chief Executive Officer

    cc:
    Carlos Ramirez, Cooley LLP

    Matthew T. Browne, Cooley LLP

[Company
Signature Page To Acceleration Request]